SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read ...
Genedx LLC partnered with Illumina Inc. to test whether Illumina's constellation map read technology could shed light on hard-to-detect variants that appear in rare diseases. Constellation met or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results